Medincell SA (MEDCL) — Capital Reinvestment Ratio

Latest as of September 2024: 0.01x

Medincell SA (MEDCL) has a Capital Reinvestment Ratio of 0.01x as of September 2024, meaning it reinvests 0% of its operating cash flow (€21.56 Million) in capital expenditures (€195.00K). Check tangible net worth ratio of Medincell SA to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

€21.56 Million
EUR

Capital Expenditures

€195.00K
EUR

Data as of

Sep 2024
Most recent filing

Medincell SA Capital Reinvestment Ratio (2016–2025)

This chart tracks Medincell SA's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see Medincell SA cash conversion from operations.

Annual Capital Reinvestment Ratio for Medincell SA (2016–2025)

Year-by-year Capital Reinvestment Ratio for Medincell SA from 2016 to 2025. See Medincell SA free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 0.09x €19.46 Million €1.66 Million ▼ -99.5%
2016 17.12x €68.00K €1.16 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow